Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study
Herana Kamal Seneviratne(University of Maryland, Baltimore County), Namandjé N. Bumpus(Johns Hopkins University), Sue Li(Fred Hutch Cancer Center), Adeola Adeyeye(National Institutes of Health), Myron S. Cohen(University of North Carolina at Chapel Hill), Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Raphael J. Landovitz(APLA Health), Marybeth McCauley(Family Health International 360), Ravindre Panchia(Chris Hani Baragwanath Hospital), Craig W. Hendrix(Unknown), Albert Liu(San Francisco Department of Public Health), Alex R. Rinehart, Irene Kuo(George Washington University), Joseph S. Eron(University of North Carolina at Chapel Hill), Gordon Chau(Fred Hutch Cancer Center), Leslie Cottle(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Allyson N. Hamlin(Johns Hopkins University), Mina C. Hosseinipour
Cited by 2
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891